OKYO Pharma LTD disclosure: Woodline Partners LP reports beneficial ownership of 3,652,190 shares of Ordinary Shares, representing 7.0% of the class based on an aggregate of 52,479,257 Ordinary Shares described in the filing. The shares are held on behalf of the Woodline Fund.
The filing states Woodline has sole voting and sole dispositive power over the 3,652,190 shares. The disclosure is formatted as a Schedule 13G beneficial-ownership statement and is signed by the reporting person’s GC and CCO.
Positive
None.
Negative
None.
Insights
Woodline reports a 7.0% stake (3,652,190 shares) in OKYO Pharma.
The filing shows Woodline Partners LP holds 3,652,190 shares with sole voting and dispositive power, disclosed on behalf of the Woodline Fund. The percent is calculated using an aggregate share base of 52,479,257.
This Schedule 13G is a passive beneficial-ownership disclosure framework; subsequent Form 13D or Form 4 filings would change the record if activism or transactions occur. Future SEC filings will show any changes in holdings.
Disclosure aligns with passive-investor Schedule 13G conventions and cites sole voting/dispositive powers.
The statement identifies the reporting person, address, CUSIP G6724L116, and that the holdings are reported on behalf of the Woodline Fund. It cites the share base used to compute 7.0%.
Signatory is the Reporting Person’s GC/CCO with a signature date of 05/15/2026. Changes in ownership or intent would require amended filings under SEC rules.
Key Figures
Reported shares beneficially owned:3,652,190 sharesPercent of class:7.0%Aggregate shares used for calculation:52,479,257 Ordinary Shares+2 more
5 metrics
Reported shares beneficially owned3,652,190 sharesAmount reported on cover page
Percent of class7.0%Calculated using aggregate of 52,479,257 Ordinary Shares
Aggregate shares used for calculation52,479,257 Ordinary SharesSum of offering, partial overallotment, and outstanding shares cited in prospectus
CUSIPG6724L116Issuer ordinary shares identifier
Signature date05/15/2026Filing signed by Erin Mullen, GC & CCO
Key Terms
Schedule 13G, beneficially owned, sole dispositive power, CUSIP
4 terms
Schedule 13Gregulatory
"The filing is formatted as a Schedule 13G beneficial-ownership statement"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially ownedfinancial
"Amount beneficially owned: The information required by Item 4(a)"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive powerregulatory
"Sole Dispositive Power 3,652,190.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
CUSIPfinancial
"CUSIP Number(s): G6724L116"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
OKYO Pharma LTD
(Name of Issuer)
Ordinary Shares, no par value
(Title of Class of Securities)
G6724L116
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
G6724L116
1
Names of Reporting Persons
Woodline Partners LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,652,190.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,652,190.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,652,190.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.0 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
OKYO Pharma LTD
(b)
Address of issuer's principal executive offices:
9th Floor, 107 Cheapside, London EC2V 6DN, United Kingdom, EC2V 6DN
Item 2.
(a)
Name of person filing:
Woodline Partners LP ("Woodline Partners" or the "Reporting Person"), a Delaware limited partnership, and the investment adviser to Woodline Master Fund LP (the "Woodline Fund"), with respect to the ordinary shares, no par value ("Ordinary Shares") of OKYO Pharma LTD (the "Company") directly held by the Woodline Fund;
The filing of this statement should not be construed as an admission that any of the foregoing persons or the Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the Ordinary Shares reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the business office of Woodline Partners is 4 Embarcadero Center, Suite 3450, San Francisco, CA 94111.
(c)
Citizenship:
Woodline Partners is a Delaware limited partnership.
(d)
Title of class of securities:
Ordinary Shares, no par value
(e)
CUSIP Number(s):
G6724L116
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for the Reporting Person and is incorporated herein by reference.
The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 52,479,257 Ordinary Shares, which is the sum of (i) 10,815,000 Ordinary Shares issued in the offering described in the Company's Prospectus filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission (the "SEC") on February 17, 2026; (ii) 1,109,060 Ordinary Shares issued pursuant to the partial exercise of the underwriters' option to purchase additional shares as reported in the Company's Report of Foreign Issuer on Form 6-K, filed with the SEC on March 12, 2026; and (iii) 40,555,197 Ordinary Shares outstanding as of February 9, 2026, as reported in the in the Company's Prospectus filed pursuant to Rule 424(b)(5) with the SEC on February 17, 2026.
(b)
Percent of class:
7.0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for the Reporting Person and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for the Reporting Person and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for the Reporting Person and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for the Reporting Person and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a). The Woodline Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Ordinary Shares.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Woodline Partners LP
Signature:
/s/ Erin Mullen
Name/Title:
Erin Mullen, General Counsel & Chief Compliance Officer
What stake does Woodline Partners report in OKYO (OKYO)?
Woodline Partners reports beneficial ownership of 3,652,190 shares, equal to 7.0% of the class. The percentage is calculated using an aggregate base of 52,479,257 Ordinary Shares disclosed in the filing.
Who holds the reported shares on behalf of Woodline Partners?
The filing states the shares are directly held by Woodline Master Fund LP (the Woodline Fund) and reported by the investment adviser, Woodline Partners LP, which has sole voting and dispositive power over the reported shares.
How was the 7.0% ownership percentage calculated?
The 7.0% figure uses an aggregate of 52,479,257 Ordinary Shares, composed of offerings and outstanding shares cited in the prospectus and related filings referenced in the Schedule 13G disclosure.
Does this Schedule 13G indicate activism or trading intent by Woodline?
The Schedule 13G is a beneficial-ownership disclosure and does not assert activist intent. It reports ownership and voting/dispositive power; any change in intent or transactions would be reflected in amended filings such as a Form 13D or Form 4.
